THEMIS MEDICARE
|
The Current P/E Ratio of THEMIS MEDICARE is -115.45.
Share Price | ₹111.5 | Aug 08,2025 |
Market Cap | ₹1,025.8 Cr | |
Earnings-TTM | ₹-8.9 Cr | TTM-Consolidated Results |
Price/Earnings | -115.45x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of THEMIS MEDICARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,025.8 Cr] as on Aug 08,2025
(/) Earnings [ ₹-8.9 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -115.45x ]
Thus, for THEMIS MEDICARE , the investors are currently willing to pay -115.45 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of THEMIS MEDICARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of THEMIS MEDICARE over the last five years.
Historical PE (Price/Earnings) ratio chart of THEMIS MEDICARE
PE Ratio Performance Analysis for THEMIS MEDICARE
- THEMIS MEDICARE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 13.10x.
- THEMIS MEDICARE 's operated at median p/e ratio of 7.21x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, THEMIS MEDICARE 's p/e ratio peaked in Mar2024 at 46.31x.
- THEMIS MEDICARE 's p/e ratio hit its five-year low in Mar2022 of 1.18x.
How does THEMIS MEDICARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
THEMIS MEDICARE | -8.89 | -115.45 | 1,025.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 36.57 | 380,702.0 |
DIVIS LABORATORIES LTD | 2,306.00 | 68.04 | 156,908.0 |
CIPLA LTD | 5,406.81 | 22.19 | 119,988.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.39 | 120,896.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 17.66 | 101,122.0 |
MANKIND PHARMA LTD | 1,905.51 | 53.41 | 101,775.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 20.40 | 94,133.2 |
LUPIN LTD | 3,722.18 | 23.52 | 87,547.0 |
AUROBINDO PHARMA LTD | 3,417.93 | 17.70 | 60,499.2 |
ABBOTT INDIA LTD | 1,414.44 | 49.31 | 69,749.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs THEMIS MEDICARE 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -115.45x |
Max industry PE | 68.04x |
Median industry PE | 23.52x |
Average industry PE | 23.07x |
You may also like the below Video Courses